Role of environmental toxicants in modulating disease severity in children with NAFLD (Q43): Difference between revisions

From wikibase
Changed an Item
Changed an Item
 
(5 intermediate revisions by the same user not shown)
Property / geographic location
 
Property / geographic location: Texas, United States of America / rank
 
Normal rank
Property / geographic location
 
Property / geographic location: Missouri, United States of America / rank
 
Normal rank
Property / participant life stages
 
Property / participant life stages: Adolescence / rank
 
Normal rank
Property / recruitment setting
 
Property / recruitment setting: Clinic Based Selection Criterion / rank
 
Normal rank
Property / primary health outcomes
 
Property / primary health outcomes: liver disease / rank
 
Normal rank
Property / parent study grant number
 
NIH-1U01-DK61718
Property / parent study grant number: NIH-1U01-DK61718 / rank
 
Normal rank

Latest revision as of 00:07, 20 December 2024

Nonalcoholic fatty liver disease (NAFLD) is a global health problem, with prevalence estimated at 20% to 30% of the general population. There is not a good understanding of why some children progress to severe disease more rapidly. While it has been
Language Label Description Also known as
English
Role of environmental toxicants in modulating disease severity in children with NAFLD
Nonalcoholic fatty liver disease (NAFLD) is a global health problem, with prevalence estimated at 20% to 30% of the general population. There is not a good understanding of why some children progress to severe disease more rapidly. While it has been

    Statements

    0 references
    Jain, Ajay
    0 references
    The National Exposure Assessment Laboratory at Emory
    0 references
    2017-1593
    0 references
    St. Louis, Chicago,Cincinnati, New York City, Atlanta, Indianoplis, Texas ( Tx Childrens hospital), San Diego, San Francisco, Seattle
    0 references
    0 references
    0 references
    0 references
    600
    0 references
    Role of environmental toxicants in modulating disease severity in children with NAFLD
    0 references
    NIH-1U01-DK61718
    0 references